Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

RTTNews | 632日前
Astellas, Poseida Announce Investment To Support Poseida's Commitment To Cancer Cell Therapy

(RTTNews) - Pharmaceutical companies Astellas Pharma Inc. (ALPMY.PK) and Poseida Therapeutics, Inc. (PSTX) announced Monday a strategic investment to support the advancement of Poseida's commitment to redefining cancer cell therapy.

Under the terms of the transaction agreements, Astellas will invest a total of $50 million, including $25 million to acquire 8.3 million shares of common stock of Poseida or approximately 8.8% of the outstanding common stock of Poseida, at $3.00 per share in a private placement.

It will also make a one-time $25 million payment for a right of exclusive negotiation and first refusal to license one of Poseida's clinical stage programs: P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy in development for multiple solid tumor indications.

In addition, Poseida has granted Astellas a board observer seat, which includes the ability to attend Poseida's scientific advisory board meetings, and certain notice rights related to any potential change of control of Poseida.

read more
Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Gets Positive CHMP Opinion For XTANDI In Early Prostate Cancer Treatment Setting

Astellas Pharma Inc. announced Friday the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of XTANDI (enzalutamide) as monotherapy or in combination with androgen deprivation therapy for the treatment of adult men with high risk biochemical recurrent (BCR) non-metastatic hormone sensitive prostate cancer (nmHSPC) who are unsuitable for salvage radiotherapy.
RTTNews | 404日前
Asian Markets Mostly Higher In Holiday Trade

Asian Markets Mostly Higher In Holiday Trade

Asian stock markets are mostly higher on Thursday, following the mixed cues from Wall Street overnight, with most major markets in the region closed for Labor Day, including China. Traders booked some profits after the recent upside in markets and a report showing the U.S. economy unexpectedly shrank in the first three months of 2025 generated some optimism about the outlook for interest rates.
RTTNews | 4分前
Japanese Market Slightly Higher

Japanese Market Slightly Higher

The Japanese market is trading slightly higher on Thursday, extending the gains in the previous five sessions, following the mixed cues from Wall Street overnight. The Nikkei 225 is moving above the 36,100 level, with a mixed performance across most sectors as traders remain cautious ahead of the Bank of Japan's latest monetary policy decision.
RTTNews | 1時30分前
Australian Market Slightly Lower

Australian Market Slightly Lower

The Australian market is trading slightly lower on Thursday, snapping a five-session winning streak, following the mixed cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying above the 8,100 level, with slight weakness across most sectors led by mining and energy stocks. Some gold stocks were gaining.
RTTNews | 2時9分前
Little Movement Seen For Japan Stock Market

Little Movement Seen For Japan Stock Market

The Japanese stock market has finished higher in five straight sessions, rallying almost 1,850 points or 5 percent along the way. The Nikkei 225 now sits just beneath the 36,050-point plateau and it's likely to hold steady in that neighborhood again on Thursday.
RTTNews | 4時1分前
Japan Rate Decision On Tap For Thursday

Japan Rate Decision On Tap For Thursday

The Bank of Japan will wrap up its monetary policy meeting on Thursday and then announce its decision on interest rates, highlighting a modest day for Asia-Pacific economic activity. The BoJ is widely expected to leave its benchmark lending rate unchanged at 0.50 percent.
RTTNews | 5時1分前